UPDATE 1-Amgen pays $71 mln to settle Enbrel, Aranesp marketing case - Reuters

UPDATE 1-Amgen pays $71 mln to settle Enbrel, Aranesp marketing case - Reuters | marketing - Google News | August 18, 2015 at 02:18PM

Portland Business Journal

UPDATE 1-Amgen pays $71 mln to settle Enbrel, Aranesp marketing case Reuters Tuesday's settlement came after Amgen agreed in December 2012 to pay $762 million to settle criminal and civil litigation over its marketing of Aranesp, Enbrel and other drugs. It also pleaded guilty to illegally introducing a misbranded drug, Aranesp ... Press Release: Amgen to Pay $71 Million for Improper Drug Marketing, AG Cooper ...Nasdaq all 20 news articles »

August 18, 2015 at 02:18PM | marketing - Google News
UPDATE 1-Amgen pays $71 mln to settle Enbrel, Aranesp marketing case - Reuters
marketing - Google News